Clinical Trial Update: Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

View source ↗

Summary

A Stanford-led clinical trial is recruiting to identify secreted biomarkers of tumor hypoxia in patients with head and neck cancer or lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Lip Cancer
• Lung Cancer

Snippet

Sponsor: Stanford University | Conditions: Head and Neck Cancer, Lung Cancer | Status: RECRUITING